ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
0,017
-0,003
(-15,00%)
Geschlossen 29 Juni 8:00AM

BioGene Technology Ltd (BGT) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
0,017
( -15,00% )
Gebot
0,016
Fragen
0,017
Volumen
2.593.142
0,016 Tagesbereich 0,02
0,016 52-Wochen-Bereich 0,061
Marktkapitalisierung
Handelsende
0,02
Handelsbeginn
0,02
Letzte Trade
51349
@
0.017
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
AUD 358.199
Ausgegebene Aktien
386.081.108
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-2,09
Gewinn pro Aktie (EPS)
-0,01
Erlöse (LTM)
-
Nettogewinn (LTM)
-2,52M

Über BioGene Technology Ltd

Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of naturally derived insecticide products in Australia and internationally. Its products include Flavocide, a synthetically produced nature-identical compound; and Qcide, a natural plant-deri... Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of naturally derived insecticide products in Australia and internationally. Its products include Flavocide, a synthetically produced nature-identical compound; and Qcide, a natural plant-derived oil with high levels of tasmanone. The company has a research collaboration agreement with James Cook University for experiments demonstrating the value of pre-conditioning biomass prior to distillation; Cesar for assessing the insecticidal activity of its molecules against a range of insect species; Advanced Molecular Technologies; CSIRO for a chemistry development process; the Department of Agriculture and Fisheries, Queensland Government for assessing activity against grain storage pests; Eurofins; Grain Research Development Corporation; Pacific Discovery Services; Purdue University; Southern Cross University for chemical analysis of natural products; University of Florida; and University of Technology. It serves animal health, crop protection, grain storage, public health, and consumer applications, as well as insect management in crop protection. The company was incorporated in 1995 and is based in Melbourne, Australia. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Hauptsitz
Melbourne, Australia
Gegründet
1995
BioGene Technology Ltd is listed in the Healthcare sector of the Australische Börse with ticker BGT. The last closing price for BioGene Technology was AUD0,02. Over the last year, BioGene Technology shares have traded in a share price range of AUD 0,016 to AUD 0,061.

BioGene Technology currently has 386.081.108 shares in issue. The market capitalisation of BioGene Technology is AUD6,56 million. BioGene Technology has a price to earnings ratio (PE ratio) of -2.09.

BGT Neueste Nachrichten

Keine Nachrichten vorhanden.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.003-150.020.0210.0164176710.02DE
4-0.008-320.0250.0250.0166678820.02083858DE
12-0.017-500.0340.040.0163732670.02405828DE
26-0.006-26.08695652170.0230.0450.0162554250.02648315DE
520.0016.250.0160.0610.0163597760.03034473DE
156-0.058-77.33333333330.0750.1050.0162709640.03872389DE
260-0.163-90.55555555560.180.350.0162370590.09194906DE

BGT - Frequently Asked Questions (FAQ)

What is the current BioGene Technology Ltd share price?
The current share price of BioGene Technology Ltd is AUD 0,017
How many BioGene Technology Ltd shares are in issue?
BioGene Technology Ltd has 386.081.108 shares in issue
What is the market cap of BioGene Technology Ltd?
The market capitalisation of BioGene Technology Ltd is AUD 6,56M
What is the 1 year trading range for BioGene Technology Ltd share price?
BioGene Technology Ltd has traded in the range of AUD 0,016 to AUD 0,061 during the past year
What is the PE ratio of BioGene Technology Ltd?
The price to earnings ratio of BioGene Technology Ltd is -2,09
What is the registered address of BioGene Technology Ltd?
The registered address for BioGene Technology Ltd is 400 Collins Street, Melbourne, Victoria, 3000
What is the BioGene Technology Ltd website address?
The website address for BioGene Technology Ltd is www.bio-gene.com.au
Which industry sector does BioGene Technology Ltd operate in?
BioGene Technology Ltd operates in the Biotechnology & Life Sciences sector

BGT Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen